9995 — RemeGen Co Balance Sheet
0.000.00%
- HK$52.05bn
- HK$53.58bn
- CNY1.72bn
Annual balance sheet for RemeGen Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
| 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — | 
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS | 
| Standards: | CAS | CAS | CAS | CAS | CAS | 
| Status: | Final | Final | Final | Final | Final | 
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 2,769 | 1,758 | 2,069 | 727 | 760 | 
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 40.3 | 41.9 | 303 | 473 | 626 | 
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,977 | 2,300 | 3,212 | 2,229 | 2,290 | 
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,021 | 1,737 | 2,663 | 3,036 | 2,975 | 
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 4,118 | 4,159 | 6,021 | 5,528 | 5,499 | 
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 425 | 612 | 877 | 1,128 | 2,178 | 
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 523 | 713 | 1,041 | 2,091 | 3,512 | 
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 3,595 | 3,446 | 4,980 | 3,437 | 1,986 | 
| Total Liabilities & Shareholders' Equity | 4,118 | 4,159 | 6,021 | 5,528 | 5,499 | 
| Total Common Shares Outstanding |